Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 20, 2020 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,843 | -- | 41,153 |
Feb 20, 2020 |
Director
Trans History: 26
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,843 | -- | 75,233 |
Feb 20, 2020 |
Director
Trans History: 8
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,843 | -- | 25,496 |
Feb 20, 2020 |
Director
Trans History: 57
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,535 | -- | 62,454 |
Feb 20, 2020 |
Director
Trans History: 57
|
Director | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 2,699 | $17.21 | 59,755 |
Feb 20, 2020 |
Director
Trans History: 22
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,843 | -- | 56,761 |
Feb 20, 2020 |
Director
Trans History: 66
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,843 | -- | 39,900 |
Feb 20, 2020 |
Director
Trans History: 7
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,843 | -- | 15,768 |
Feb 20, 2020 |
Director
Trans History: 79
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,843 | -- | 55,328 |
Feb 20, 2020 |
Director
Trans History: 98
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,843 | -- | 58,123 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.